# PeRiOperative Medicine Platform Trial

> **NCT07186634** · PHASE4 · RECRUITING · sponsor: **Monash University** · enrollment: 7800 (estimated)

## Conditions studied

- Surgical Site Infection After Major Surgery
- Anaesthesia
- Major Complications
- Quality of Recovery (QoR-15)
- Quality of Life

## Interventions

- **DRUG:** Liberal inspired oxygen
- **DRUG:** Conservative inspired oxygen
- **DRUG:** Intermediate inspired oxygen

## Key facts

- **NCT ID:** NCT07186634
- **Lead sponsor:** Monash University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-06
- **Primary completion:** 2035-12
- **Final completion:** 2035-12
- **Target enrollment:** 7800 (ESTIMATED)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07186634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07186634, "PeRiOperative Medicine Platform Trial". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07186634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*